Canton Strategic Holdings CNTN
NASDAQ CNTN
$2.28 +0.03 (+1.33%)
As of: Sep 4, 2026 · 3:59 PM EDT

Canton Strategic Holdings (CNTN) Other Non Operating Income (2025 - 2026)

Canton Strategic Holdings' (CNTN) quarterly Other Non Operating Income came in at $318178.0 in Q1 2026, up 6308.42% YoY from $4965.0 in Q1 2025, and up 6308.42% on a QoQ basis from $4965.0 in Q1 2025.

Generated on {Timestamp} © BusinessQuant.com
Generated on {Timestamp} Powered by BusinessQuant Logo
Analysis

Canton Strategic Holdings (CNTN) Other Non Operating Income (2025 - 2026) Analysis & Trends

Canton Strategic Holdings (CNTN) has 2 years of Other Non Operating Income data on file, last reported at $318178.0 in Q1 2026.

Peer Set

Peer Comparison

All peers
# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn
10 Canton Strategic Holdings 493.37 Mn 493.37 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 311,848.00
Mar 31, 2026 318,178.00
Jun 30, 2025 -3,993.00
Mar 31, 2025 4,965.00